Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), an innovative cancer drug discovery and development company, is focused on discovering, developing, and delivering best-in-class medicines designed to treat cancer and related conditions. The company leverages its proven scientific expertise and passion for developing novel small molecule drugs designed to target emerging cancer pathways. Infinity’s two most advanced programs are examples of its innovative approach to oncology drug discovery and development. For further information, visit the Company’s web site at www.infi.com.
- 18 years ago
QualityStocks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Frontieras North America Inc. Advancing FASForm(TM) for Domestic, Feedstock-Driven Energy Production
Frontieras is positioned amid increased demand for domesticenergy production. “At the core of its strategy is…
-
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Expands Gold Asset Portfolio in Abitibi Supporting Mine-to-Mill Platform
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid…
-
American Fusion(TM) Inc. (AMFN) Expands into Government Procurement While Advancing Fusion Energy Development
American Fusion(TM) launched a Government Procurement Services segment alongside its fusion energy development business. The…